Synchron Halts Brain Implant Trials Over Performance Issues
Brain-computer interface startup Synchron has paused clinical trials after its latest device failed to perform. The company intends to upgrade the implant’s hardware and is developing a new version.
The setback underscores the difficulties in developing reliable neural implants.
Read the full coverage
More on: Startups & Funding
This brief was written with AI from the headlines and excerpts published by the outlets above, and may contain errors. Follow the links for the original reporting.